Kerry Brown v. Pharmchem Laboratories, Inc., J. Michael Quinlan, Calvin Edwards, Eddie Geouge, G. Quinn, S. King, Gary L. Henman

2 F.3d 1160, 1993 U.S. App. LEXIS 32282, 1993 WL 307943
CourtCourt of Appeals for the Tenth Circuit
DecidedAugust 10, 1993
Docket92-3402
StatusPublished

This text of 2 F.3d 1160 (Kerry Brown v. Pharmchem Laboratories, Inc., J. Michael Quinlan, Calvin Edwards, Eddie Geouge, G. Quinn, S. King, Gary L. Henman) is published on Counsel Stack Legal Research, covering Court of Appeals for the Tenth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Kerry Brown v. Pharmchem Laboratories, Inc., J. Michael Quinlan, Calvin Edwards, Eddie Geouge, G. Quinn, S. King, Gary L. Henman, 2 F.3d 1160, 1993 U.S. App. LEXIS 32282, 1993 WL 307943 (10th Cir. 1993).

Opinion

2 F.3d 1160

NOTICE: Although citation of unpublished opinions remains unfavored, unpublished opinions may now be cited if the opinion has persuasive value on a material issue, and a copy is attached to the citing document or, if cited in oral argument, copies are furnished to the Court and all parties. See General Order of November 29, 1993, suspending 10th Cir. Rule 36.3 until December 31, 1995, or further order.

Kerry BROWN, Plaintiff-Appellant,
v.
PHARMCHEM LABORATORIES, INC., J. Michael Quinlan, Calvin
Edwards, Eddie Geouge, G. Quinn, S. King, Gary L.
Henman, Defendants-Appellees.

No. 92-3402.

United States Court of Appeals, Tenth Circuit.

Aug. 10, 1993.

D.Kan., 1992 WL 266550.

AFFIRMED.

D.Kan., No. 92-CV-3010.

Before LOGAN and BRORBY, Circuit Judges, and BRIMMER,* District Judge.

ORDER AND JUDGMENT**

BRIMMER, District Judge.

After examining the briefs and appellate record, this panel has determined unanimously that oral argument would not materially assist the determination of this appeal. See Fed.R.App.P. 34(a); 10th Cir.R. 34.1.9. The case is therefore ordered submitted without oral argument.

Plaintiff-appellant Kerry Brown is a prisoner at the United States Penitentiary in Leavenworth, Kansas. This case arises out of urine tests that prison officials required Mr. Brown to take in 1990 and 1991. Mr. Brown provided urine samples on three occasions that were analyzed by defendant PharmChem Laboratories, Inc., and were found to test positive for narcotics. Based on PharmChem's findings, prison officials charged Mr. Brown with possession or use of narcotics. After disciplinary proceedings including hearings, Mr. Brown was found guilty of the charges on all three occasions and each time was punished with disciplinary segregation, forfeiture of statutory good time, and suspension of visitation rights.

Mr. Brown brought this action against PharmChem and various federal prison employees, alleging that the testing and resulting disciplinary actions violated his civil rights,1 the Racketeer Influenced and Corrupt Organizations Act (RICO), 18 U.S.C. Secs. 1962, 1964, and 1968, and prison regulations. His civil rights claims allege that his Fifth and Eighth Amendment rights were violated because he did not receive due process during his disciplinary hearings, he was subjected to double jeopardy by being charged twice for the same incident, and his punishment of segregation and loss of visitation rights amounted to cruel and unusual punishment. He also alleged that defendants committed mail and wire fraud and conspired to prolong his imprisonment and "maintain the lucrative existing contracts" between PharmChem and the federal government. PharmChem filed a motion to dismiss for failure to state a claim under Fed.R.Civ.P. 12(b)(6). In response, Mr. Brown contended that he stated a valid RICO claim but did not argue in support of his other claims against PharmChem. The federal employees then filed their own motion to dismiss or, in the alternative, for summary judgment. The district court ordered Mr. Brown to show cause why the federal employees' motion to dismiss or for summary judgment should not be granted, and Mr. Brown filed a response to the motion.

The district court granted PharmChem's motion to dismiss, finding that PharmChem was not an agent of the federal government, that Mr. Brown did not identify any action taken by PharmChem which might subject it to liability under Bivens, and that his claims were insufficient to state a cause of action under either 42 U.S.C. Sec. 1983 or RICO. The district court also granted the federal employees' motion for summary judgment.2 It found that Mr. Brown's due process claim failed and that there was evidence in the record supporting the conclusions reached by the disciplinary boards. See Superintendent, Mass. Correctional Inst. v. Hill, 472 U.S. 445, 455-56 (1985). Next, it granted qualified immunity to the employees on Mr. Brown's claim that he should have been provided with test results at the time of his hearings. The court concluded that the law is not settled to a degree requiring reasonably competent officials to supply test results to a prisoner. See Harrison v. Dahm, 911 F.2d 37, 40-41 (8th Cir.1990). Third, the court found that Mr. Brown did not have a constitutionally protected interest in remaining in a particular location inside the prison, see Kentucky Dep't of Corrections v. Thompson, 490 U.S. 454, 460-61 (1989), and that his Eighth Amendment claim involving his segregation for disciplinary purposes failed. Finally, the district court determined that his loss of visitation rights was not disproportionate to the charges of which he was found guilty and did not amount to cruel and unusual punishment.

Mr. Brown filed a timely notice of appeal of the district court's dismissal of his complaint. We have jurisdiction under 28 U.S.C. Sec. 1291 and review the district court's grant of both the Rule 12(b)(6) motion and summary judgment de novo, see Ayala v. Joy Mfg. Co., 877 F.2d 846, 847 (10th Cir.1989), and Applied Genetics Int'l, Inc. v. First Affiliated Sec., Inc., 912 F.2d 1238, 1241 (10th Cir.1990).

Because Mr. Brown proceeds pro se, we construe his pleadings liberally. Haines v. Kerner, 404 U.S. 519, 520-21 (1972). However, our "broad reading of the plaintiff's complaint does not relieve the plaintiff of the burden of alleging sufficient facts on which a recognized legal claim could be based." Hall v. Bellmon, 935 F.2d 1106, 1110 (10th Cir.1991).3 We agree with the district court that Mr. Brown's conclusory allegations of conspiracy and mail and wire fraud fail to adequately state a RICO claim. See Cayman Exploration Corp. v. United Gas Pipe Line Co., 873 F.2d 1357, 1362 (10th Cir.1989). Assuming without deciding that a Bivens claim may be stated against a private party, see DeVargas v. Mason & Hanger-Silas Mason Co., 844 F.2d 714, 720 n. 5 (10th Cir.1988), we also agree with the district court that Mr. Brown has failed to state a valid civil rights claim against PharmChem. We therefore affirm the district court's grant of PharmChem's motion to dismiss.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Haines v. Kerner
404 U.S. 519 (Supreme Court, 1972)
Wolff v. McDonnell
418 U.S. 539 (Supreme Court, 1974)
Kentucky Department of Corrections v. Thompson
490 U.S. 454 (Supreme Court, 1989)
Martinez v. Aaron
570 F.2d 317 (Tenth Circuit, 1978)
Phillips v. Carey
638 F.2d 207 (Tenth Circuit, 1981)
United States v. Walter Michael Rising
867 F.2d 1255 (Tenth Circuit, 1989)
Steven M. Harrison v. John Dahm, Etc.
911 F.2d 37 (Eighth Circuit, 1990)
Bacchus Industries, Inc. v. Arvin Industries, Inc.
939 F.2d 887 (Tenth Circuit, 1991)
Gorman v. Moody
710 F. Supp. 1256 (N.D. Indiana, 1989)
DeVargas v. Mason & Hanger-Silas Mason Co.
844 F.2d 714 (Tenth Circuit, 1988)
Hall v. Bellmon
935 F.2d 1106 (Tenth Circuit, 1991)
Miller v. Glanz
948 F.2d 1562 (Tenth Circuit, 1991)
Jones v. Carroll
429 U.S. 1033 (Supreme Court, 1977)
Benfield v. Bounds
540 F.2d 670 (Fourth Circuit, 1976)

Cite This Page — Counsel Stack

Bluebook (online)
2 F.3d 1160, 1993 U.S. App. LEXIS 32282, 1993 WL 307943, Counsel Stack Legal Research, https://law.counselstack.com/opinion/kerry-brown-v-pharmchem-laboratories-inc-j-michael-ca10-1993.